642 research outputs found
Clinical efficacy of azole therapy for Trichosporon fungemia in patients with acute leukeima
Detection of Gamma-rays around 1TeV from RX J0852.0-4622 by CANGAROO-II
We have detected gamma-ray emission at the 6sigma level at energies greater
than 500GeV from the supernova remnant RX J0852.0-4622 (G266.2-1.2) using the
CANGAROO-II Imaging Atmospheric Cherenkov Telescope (IACT). The flux was 0.12
times of that of Crab at 1TeV. The signal centroid is consistent with the peak
of the X-ray emission in the north-west rim of the remnant.Comment: 12pages, 4figures, to be published in ApJ
Design Study of CANGAROO-III, Stereoscopic Imaging Atmospheric Cherenkov Telescopes for sub-TeV Gamma-ray
CANGAROO-III is an Imaging Atmospheric Cherenkov Telescope (IACT) array of
four 10 m telescopes for very high energy (sub-TeV) gamma-ray astronomy. A
design study of the CANGAROO-III telescope system was carried out using the
Monte Carlo technique in order to optimize the pixel size and the telescope
spacing. Studies were also made of observations at low elevation angles.Comment: 17pages, 13 figures, elsart, to appear in Astro. Part. Phy
Search for VHE gamma rays from SS433/W50 with the CANGAROO-II telescope
SS433, located at the center of the supernova remnant W50, is a close
proximity binary system consisting of a compact star and a normal star. Jets of
material are directed outwards from the vicinity of the compact star
symmetrically to the east and west. Non-thermal hard X-ray emission is detected
from lobes lying on both sides. Shock accelerated electrons are expected to
generate sub-TeV gamma rays through the inverse-Compton process in the lobes.
Observations of the western X-ray lobe region of SS433/W50 system have been
performed to detect sub-TeV gamma-rays using the 10m CANGAROO-II telescope in
August and September, 2001, and July and September, 2002. The total observation
times are 85.2 hours for ON source, and 80.8 hours for OFF source data. No
significant excess of sub-TeV gamma rays has been found at 3 regions of the
western X-ray lobe of SS433/W50 system. We have derived 99% confidence level
upper limits to the fluxes of gamma rays and have set constraints on the
strengths of the magnetic fields assuming the synchrotron/inverse-Compton model
for the wide energy range of photon spectrum from radio to TeV. The derived
lower limits are 4.3 microgauss for the center of the brightest X-ray emission
region and 6.3 microgauss for the far end from SS433 in the western X-ray lobe.
In addition, we suggest that the spot-like X-ray emission may provide a major
contribution to the hardest X-ray spectrum in the lobe.Comment: 7 pages, 8 figures, to be published in Astroparticle Physic
Detection of diffuse TeV gamma-ray emission from the nearby starburst galaxy NGC 253
We report the TeV gamma-ray observations of the nearby normal spiral galaxy
NGC 253. At a distance of 2.5 Mpc, NGC 253 is one of the nearest
starburst galaxies. This relative closeness, coupled with the high star
formation rate in the galaxy, make it a good candidate TeV gamma-ray source.
Observations were carried out in 2000 and 2001 with the CANGAROO-II 10 m
imaging atmospheric Cerenkov telescope. TeV gamma-ray emission is detected at
the level with a flux of at energies 0.5 TeV. The data indicate that the
emission region is broader than the point spread function of our telescope.Comment: 4 pages, double colomn, 3 figures, aa.cl
Search for TeV gamma-rays from SN 1987A in 2001
We searched for TeV gamma-rays from the remnant of SN 1987A around 5400 days
after the supernova. The observations were carried out in 2001, from November
16 to December 11, using the CANGAROO-II Imaging Atmospheric Cherenkov
Telescope. In total, 708 minutes of ON- and 1019 minutes of OFF-source data
were obtained under good conditions. The detection threshold was estimated to
be 1 TeV, due to the mean zenith angle of 39. The upper limits for the
gamma-ray flux were obtained and compared with the previous observations and
theoretical models. The observations indicate that the gamma-ray luminosity is
lower than erg s at TeV.Comment: 8 pages, 3 figures, submitted for publication, style file adde
Evidence of TeV gamma-ray emission from the nearby starburst galaxy NGC 253
TeV gamma-rays were recently detected from the nearby normal spiral galaxy
NGC 253 (Itoh et al., 2002). Observations to detect the Cherenkov light images
initiated by gamma-rays from the direction of NGC 253 were carried out in 2000
and 2001 over a total period of 150 hours. The orientation of images in
gamma-ray--like events is not consistent with emission from a point source, and
the emission region corresponds to a size greater than 10 kpc in radius. Here,
detailed descriptions of the analysis procedures and techniques are given.Comment: 16 pages, 27 figures, aa.cl
Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke
<p>Abstract</p> <p>Background</p> <p>Although free radicals have been reported to play a role in the expansion of ischemic brain lesions, the effect of free radical scavengers is still under debate. In this study, the temporal profile of ischemic stroke lesion sizes was assessed for more than one year to evaluate the effect of edaravone which might reduce ischemic damage.</p> <p>Methods</p> <p>We sequentially enrolled acute ischemic stroke patients, who admitted between April 2003 and March 2004, into the edaravone(-) group (n = 83) and, who admitted between April 2004 and March 2005, into the edaravone(+) group (n = 93). Because, edaravone has been used as the standard treatment after April 2004 in our hospital. To assess the temporal profile of the stroke lesion size, the ratio of the area [T2-weighted magnetic resonance images (T2WI)/iffusion-weighted magnetic resonance images (DWI)] were calculated. Observations on T2WI were continued beyond one year, and observational times were classified into subacute (1-2 months after the onset), early chronic (3-6 month), late chronic (7-12 months) and old (≥13 months) stages. Neurological deficits were assessed by the National Institutes of Health Stroke Scale upon admission and at discharge and by the modified Rankin Scale at 1 year following stroke onset.</p> <p>Results</p> <p>Stroke lesion size was significantly attenuated in the edaravone(+) group compared with the edaravone(-) group in the period of early and late chronic observational stages. However, this reduction in lesion size was significant within a year and only for the small-vessel occlusion stroke patients treated with edaravone. Moreover, patients with small-vessel occlusion strokes that were treated with edaravone showed significant neurological improvement during their hospital stay, although there were no significant differences in outcome one year after the stroke.</p> <p>Conclusion</p> <p>Edaravone treatment reduced the volume of the infarct and improved neurological deficits during the subacute period, especially in the small-vessel occlusion strokes.</p
- …